Management of COVID-19 myopericarditis with reversal of cardiac dysfunction after blunting of cytokine storm: a case report.

Angela Li Youssef Garcia-Bengochea Richard Stechel Bani M Azari

Published in: European heart journal. Case reports (2020)

COVID-19's complex and devastating complications continue to create new challenges for clinicians. Cardiac complications, specifically, have been shown to be a signal for worse prognosis in these patients. IVIG and steroids can inhibit the inflammatory cascade and decrease myocardial injury, with implications in treatment of severe myopericarditis.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
oxidative stress
left ventricular
newly diagnosed
ejection fraction
risk factors
prognostic factors
early onset
palliative care
patient reported outcomes
respiratory syndrome coronavirus
combination therapy
smoking cessation